SCHEMBL7279772

SCHEMBL7279772

CCCC(=O)C(=Cc1cccc([N+](=O)[O-])c1)C(=O)O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GLO1 Q04760 2/20 0.64
▸ FBP1 P09467 1/20 0.51
▸ ALDH1A1 P00352 5/20 0.51
▸ KMT2A Q03164 3/20 0.51
▸ LMNA P02545 2/20 0.51
▸ KDM4E B2RXH2 1/20 0.51
▸ MEN1 O00255 2/20 0.51
▸ SMN1; SMN2 Q16637 2/20 0.49
▸ NPSR1 Q6W5P4 1/20 0.49
▸ NFE2L2 Q16236 1/20 0.49
▸ TRPM8 Q7Z2W7 1/20 0.48
▸ HTT P42858 2/20 0.47
▸ GAA P10253 1/20 0.47
▸ MAPT P10636 2/20 0.47
▸ MAOB P27338 1/20 0.47
▸ CA1 P00915 1/20 0.47
▸ CA2 P00918 1/20 0.47
▸ CA4 P22748 1/20 0.47
▸ CA7 P43166 1/20 0.47
▸ PAX8 Q06710 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7483326 1.00 GLO1 (0.64) GLO1FBP1ALDH1A1KMT2ALMNA
SCHEMBL7272467 0.89 GLO1 (0.68) GLO1FBP1ALDH1A1KMT2ALMNA
SCHEMBL10690139 0.89 GLO1 (0.68) GLO1FBP1ALDH1A1KMT2ALMNA
SCHEMBL10690145 0.89 GLO1 (0.68) GLO1FBP1ALDH1A1KMT2ALMNA
SCHEMBL6177870 0.86 GLO1 (0.74) GLO1FBP1KMT2ALMNAMEN1
SCHEMBL11327355 0.85 GLO1 (0.58) GLO1FBP1ALDH1A1KMT2ALMNA
SCHEMBL11327350 0.85 GLO1 (0.58) GLO1FBP1ALDH1A1KMT2ALMNA
SCHEMBL30648612 0.85 GLO1 (0.58) GLO1FBP1ALDH1A1KMT2ALMNA
SCHEMBL7281955 0.84 GLO1 (0.57) GLO1FBP1ALDH1A1KMT2ALMNA
SCHEMBL28394941 0.84 GLO1 (0.60) GLO1FBP1ALDH1A1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0747357-B1 Dihydropyridine NPY antagonists: piperidine derivatives BRISTOL MYERS SQUIBB CO (US) 2002-01-09 — — EP disclosed
CN-1042727-C Preparing for 2-acetoacetic ester XINHUA PHARMACEUTIC FACTORY SH (CN) 1999-03-31 — — CN disclosed
US-5668151-A USEFUL AS ANOREXIGENIC AGENTS IN PROMOTING WEIGHT LOSS AND TREATING EATING DISORDERS BRISTOL-MYERS SQUIBB COMPANY (US) 1997-09-16 — — US disclosed
US-5635503-A TREATMENT OF EATING DISORDERS, PROMOTING WEIGHT LOSS BRISTOL-MYERS SQUIBB COMPANY (US) 1997-06-03 — — US disclosed
EP-0747357-A2 Dihydropyridine NPY antagonists: piperidine derivatives BRISTOL-MYERS SQUIBB COMPANY (US) 1996-12-11 — — EP disclosed
EP-0747378-A1 Dihydropyridine NPY antagonists BRISTOL-MYERS SQUIBB COMPANY (US) 1996-12-11 — — EP disclosed
EP-0747356-A1 Dihydropyridine NPY antagonists: piperazine derivatives BRISTOL-MYERS SQUIBB COMPANY (US) 1996-12-11 — — EP disclosed
US-5554621-A Dihydropyridine NPY antagonists: nitrogen heterocyclic derivatives BRISTOL-MYERS SQUIBB COMPANY (US) 1996-09-10 — — US disclosed
CN-1080631-A 2-(oil of mirbane methylene radical) acetylacetic ester method for making SHANDONG XINHUA PHARMACEUTIC F (CN) 1994-01-12 — — CN disclosed
EP-0114273-B1 NEW PHARMACOLOGICALLY ACTIVE PYRAZOLOPYRIDINES GRUPPO LEPETIT S.p.A. (IT) 1991-11-06 — — EP disclosed
US-4954508-A HYPOTENSIVE GRUPPO LEPETIT S.P.A. (IT) 1990-09-04 — — US disclosed
EP-0114273-A1 New pharmacologically active pyrazolopyridines GRUPPO LEPETIT S.p.A. (IT) 1984-08-01 — — EP disclosed
Send feedback